The European Antibiotic Awareness Day 2020 was planned in the week from 11 till 17 November, but due to the Corona virus the event is cancelled. The aim of this European public health initiative is to raise awareness about the threat of antibiotic resistance to public health and the importance of prudent antibiotic use. The number of patients infected by resistant bacteria is increasing across the European Union, causing a major threat to public health. To reduce the development of resistant bacteria prudent use of antibiotics is very important and this will help to keep effective antibiotics available for future generations.
AIMMS researchers of the STAR PLUS program work in the field of antibiotic resistance and development. They are trying to increase the understanding of resistance development and to find new antibiotic targets. Underneath you can find a list of ongoing antibiotic research projects. If you click on the links you will read about the current status of the research projects.
Design of peptide-derived antibiotics that block interactions between bacterial cell division proteins
Development of new molecular strategies by identifying and characterizing switching factors in Mycobacterium tuberculosis
Bacterial energy metabolism as potential anti-tuberculosis target
The STAR PLUS has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 713669.